JG
BSTC

Jefferies Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Jefferies Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,758
Closed -$206K – 2904
2017
Q4 		$206K Buy
+4,758
New +$214K ﹤0.01% 2206
2015
Q3 		– Sell
-86
Closed -$4K – 3333
2015
Q2 		$4K Buy
+86
New +$3.67K ﹤0.01% 3056

Other funds holding BSTC

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jefferies Group's BSTC Position: Q1 2018 in Review

Jefferies Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2018, closing a stake of 4,758 shares — an estimated $206K sold.

Jefferies Group first reported a position in BSTC in Q2 2015 and held it in 2 quarters. The position peaked at $206K in Q4 2017. 78 funds tracked by Wall St. Rank hold BSTC as of Q1 2018.

  • Jefferies Group reported no remaining BioSpecifics Technologies Corp. position as of Q1 2018 after selling out during the quarter.
  • Jefferies Group sold 4,758 BioSpecifics Technologies Corp. shares in Q1 2018, an estimated $206K.
  • Jefferies Group first reported a position in BioSpecifics Technologies Corp. in Q2 2015 and held it in 2 quarters.
  • Jefferies Group's BioSpecifics Technologies Corp. position peaked at $206K in Q4 2017.
  • 78 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2018.

Based on Jefferies Group's 13F filing for Q1 2018, filed 15 May 2018.